$NTLA Intellia Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intellia Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Intellia Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Intellia Therapeutics, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Atlas Venture Associates IX, L.P. | 10% Owner | 5,504 | 73,203 | Mar 13 2017 | |||
| Atlas Venture Fund IX, L.P. | 10% Owner | 3,699,788 | 49,207,180 | Jul 11 2017 | |||
| BAKER BROS ADVISORS LLC | 976,214 | 12,983,646 | May 11 2016 | ||||
| Barnes Thomas M. | SVP, R&D eXtellia | 0 | 0 | Jan 10 2017 | |||
| Bell Graeme | EVP, Chief Financial Officer | 21,400 | 284,620 | Mar 30 2018 | |||
| Bermingham Nessan | President & CEO | 696,000 | 9,256,800 | Dec 14 2017 | |||
| Caribou Biosciences, Inc. | 3,994,355 | 53,124,922 | Jan 30 2018 | ||||
| Caribou Therapeutics Holdco, LLC | 10% Owner | 5,593,846 | 74,398,152 | May 11 2016 | |||
| Cohen Fred E | Director | 30,000 | 399,000 | Jan 22 2021 | |||
| Crowley John F | Director | 2,094 | 27,850 | Jun 25 2021 | |||
| DORSA CAROLINE | Director | 12,910 | 171,703 | Apr 06 2021 | |||
| FORMELA JEAN FRANCOIS | Director | 765,101 | 10,175,843 | Apr 30 2021 | |||
| Goddard Glenn | EVP, Chief Financial Officer | 0 | 0 | Mar 05 2021 | |||
| GOODMAN JESSE | Director | 0 | 0 | Jun 19 2020 | |||
| GORDON CARL L | Director | 2,662,180 | 35,406,994 | May 19 2017 | |||
| Haurwitz Rachel E. | Director | 5,593,846 | 74,398,152 | May 11 2016 | |||
| Heifner Nicole | SVP, Accounting | 0 | 0 | Jan 10 2017 | |||
| KARSEN PERRY A | Director | 36,764 | 488,961 | Dec 18 2020 | |||
| Keresty Georgia | Director | 4,955 | 65,902 | Apr 13 2021 | |||
| Lebwohl David | EVP, Chief Medical Officer | 0 | 0 | Mar 05 2021 | |||
| LEONARD JOHN M. | President and CEO | 703,368 | 9,354,794 | Apr 15 2021 | |||
| Morrissey David V | SVP, Platform & Delivery Tech | 0 | 0 | Jan 10 2017 | |||
| Novartis Institutes for BioMedical Research, Inc. | 10% Owner | 4,129,903 | 54,927,710 | Dec 14 2017 | |||
| ORBIMED ADVISORS LLC | Director | 2,662,180 | 35,406,994 | May 13 2016 | |||
| Rivera Jose E | EVP, General Counsel | 148,842 | 1,979,599 | Apr 02 2021 | |||
| SCHIERMEIER ANDREW | EVP, Chief Operating Officer | 18,033 | 239,839 | Mar 05 2021 | |||
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 0 | 0 | Mar 05 2021 | |||
| Slaoui Moncef | Director | 0 | 0 | Jul 25 2017 | |||
| TEMASEK HOLDINGS LTD | 10% Owner | 790,527 | 10,514,009 | May 13 2016 | |||
| Verwiel Frank | Director | 0 | 0 | Jun 19 2020 |